Corrigendum: Urokinase-type plasminogen activator and plasminogen activator inhibitor-1 complex as a serum biomarker for COVID-19

Affiliations

• ¹ Department of Research Support Utilizing Bioresource Bank, Graduate School of Medicine, Juntendo University School of Medicine, Tokyo, Japan.
• ² Department of Enzymes Chemistry and Biochemistry, Palladin Institute of Biochemistry of the National Academy of Science of Ukraine, Kyiv, Ukraine.
• ³ Institute of Computing, Federal University of Bahia, Salvador, Bahia, Brazil.
• ⁴ An-Najah Center for Cancer and Stem Cell Research, Faculty of Medicine and Health Sciences, An-Najah National University, Nablus, Palestine.
• ⁵ Division of Clinical Precision Research Platform, the Institute of Medical Science, the University of Tokyo, Tokyo, Japan.
• ⁶ Department of Respiratory Medicine, Juntendo University School of Medicine, Tokyo, Japan.
• ⁷ Center for Genome and Regenerative Medicine, Juntendo University, Graduate School of Medicine, Tokyo, Japan.
• ⁸ Department of Hematology/Oncology, the Institute of Medical Science, the University of Tokyo, Tokyo, Japan.